Olivo labs and Shiseido

In January, 2018 Olivo Laboratories sold its XPL™ technology to Shiseido Company, Limited for use in cosmetic applications. Olivo retained the rights to the therapeutic product for applications such as treatment of atopic dermatitis.

“We are delighted to work with Shiseido, a company that has the vision, resources and talent to be pioneers in beauty science and to create a new standard for skincare in the beauty industry.”
— Amy Schulman, CEO of Olivo